Intervention not reported
Myocardial infarction · people with resistant hypertension
1 finding from 1 review
Intervention not reported
Serum creatinine (mg/dL) · people with resistant hypertension
1 finding from 1 review
Intervention not reported
Ischaemic stroke · people with resistant hypertension
1 finding from 1 review
Intervention not reported
Unstable angina · people with resistant hypertension
1 finding from 1 review
Intervention not reported
Hospitalisation · people with resistant hypertension
1 finding from 1 review
Intervention not reported
Systolic 24‐hour ABPM (mmHg) · people with resistant hypertension
1 finding from 1 review
Intervention not reported
Diastolic 24‐hour ABPM (mmHg) · people with resistant hypertension
1 finding from 1 review
Intervention not reported
Systolic office BP (mmHg) · people with resistant hypertension
1 finding from 1 review
Intervention not reported
Diastolic office BP (mmHg) · people with resistant hypertension
1 finding from 1 review
Intervention not reported
eGFR or creatinine clearance (mL/min/1.73m²) · people with resistant hypertension
1 finding from 1 review
All‐cause mortality · adults (18 years of age or older) with hypertension‐induced left ventricular hypertrophy
It is very uncertain whether antihypertensive therapy changes all‐cause mortality compared with placebo or no treatment (very low certainty).
1 finding from 1 review
Cardiovascular events · adults (18 years of age or older) with hypertension‐induced left ventricular hypertrophy
It is very uncertain whether antihypertensive therapy changes cardiovascular events compared with placebo or no treatment (very low certainty).
1 finding from 1 review
Total serious adverse events · adults (18 years of age or older) with hypertension‐induced left ventricular hypertrophy
It is very uncertain whether antihypertensive therapy changes total serious adverse events compared with placebo or no treatment (very low certainty).
1 finding from 1 review
Heart failure hospitalisation (RR) · adults (18 years of age or older) with hypertension‐induced left ventricular hypertrophy
It is very uncertain whether antihypertensive therapy changes hospitalisation for heart failure compared with placebo or no treatment (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · adults (18 years of age or older) with hypertension‐induced left ventricular hypertrophy
It is very uncertain whether antihypertensive therapy changes withdrawal due to adverse events compared with placebo or no treatment (very low certainty).
1 finding from 1 review
Intervention not reported
Total testosterone · Male participants
1 finding from 1 review
Intervention not reported
Acronyms and grades · Male participants
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Total testosterone · Adult female participants with PCOS
1 finding from 1 review
Intervention not reported
FAI · Adult female participants with PCOS
1 finding from 1 review
Intervention not reported
SHBG · Adult female participants with PCOS
1 finding from 1 review